871
Views
3
CrossRef citations to date
0
Altmetric
Clinical Study

C4d deposition is associated with immune cells infiltrating in kidney allograft glomerulitis and peritubular capillaritis

, &
Pages 791-797 | Received 07 Nov 2014, Accepted 18 Mar 2015, Published online: 14 Apr 2015

Figures & data

Table 1. Demographic date and clinical characteristics of patients.

Figure 1. Example of the glomerulitis and immunostaining for two markers (×400, DAB stain × 400): (A) glomerulitis with HE stain (arrow); (B) CD3-positive controls; (C) CD3-negative controls; (D) CD3-positive T lymphocytes in the glomerulus (arrow); (E) glomerulitis with PAS stain (arrow); (F) CD68-positive controls. (G) CD68-negative controls; (H) CD68-positive T lymphocytes in the glomerulus (arrow).

Figure 1. Example of the glomerulitis and immunostaining for two markers (×400, DAB stain × 400): (A) glomerulitis with HE stain (arrow); (B) CD3-positive controls; (C) CD3-negative controls; (D) CD3-positive T lymphocytes in the glomerulus (arrow); (E) glomerulitis with PAS stain (arrow); (F) CD68-positive controls. (G) CD68-negative controls; (H) CD68-positive T lymphocytes in the glomerulus (arrow).

Figure 2. Example of the two PTCitis scores immunostaining for two markers (PAS stain × 1000, DAB stain × 1000). (A) Capillaritis with a PTCitis-score 1, i.e., max 3–4 luminal inflammatory cells in PTC (arrow). (B) Capillaritis with a PTCitis-score 2, i.e., max 5–10 luminal inflammatory cells in PTC (arrow). (C) CD3-positive T lymphocytes in the PTC (arrow). (D) CD68-positive macrophages in the PTC (arrow).

Figure 2. Example of the two PTCitis scores immunostaining for two markers (PAS stain × 1000, DAB stain × 1000). (A) Capillaritis with a PTCitis-score 1, i.e., max 3–4 luminal inflammatory cells in PTC (arrow). (B) Capillaritis with a PTCitis-score 2, i.e., max 5–10 luminal inflammatory cells in PTC (arrow). (C) CD3-positive T lymphocytes in the PTC (arrow). (D) CD68-positive macrophages in the PTC (arrow).

Figure 3. Immunostaining for C4d (DAB stain × 1000). (A) Negative C4d stain in PTC (arrow). (B) Minimal C4d stain/positive in PTC (arrow), i.e., C4d deposition in < 10% PTCs. (C) Focal C4d stain/positive in PTC (arrow), i.e., C4d deposition in 10–50% PTCs. (D) Diffuse C4d stain/positive in PTC (arrow), i.e., C4d deposition in > 50% PTCs.

Figure 3. Immunostaining for C4d (DAB stain × 1000). (A) Negative C4d stain in PTC (arrow). (B) Minimal C4d stain/positive in PTC (arrow), i.e., C4d deposition in < 10% PTCs. (C) Focal C4d stain/positive in PTC (arrow), i.e., C4d deposition in 10–50% PTCs. (D) Diffuse C4d stain/positive in PTC (arrow), i.e., C4d deposition in > 50% PTCs.

Table 2. Quantitative analysis of biopsy findings for C4d+ and C4d groups.

Figure 4. Immunostaining for granzyme-B (DAB stain × 1000). (A) Granzyme B-positive controls (arrow). (B) Granzyme B-negative controls (arrow). (C) Granzyme B-positive T lymphocytes in the glomerulus (arrow). (D) Granzyme B-positive T lymphocytes in the PTC (arrow).

Figure 4. Immunostaining for granzyme-B (DAB stain × 1000). (A) Granzyme B-positive controls (arrow). (B) Granzyme B-negative controls (arrow). (C) Granzyme B-positive T lymphocytes in the glomerulus (arrow). (D) Granzyme B-positive T lymphocytes in the PTC (arrow).

Figure 5. Immunostaining for Foxp3 (DAB stain × 1000). (A) Foxp3-positive controls. (B) Foxp3-negative controls (arrow). (C) Foxp3-negative T lymphocytes in the glomerulus (arrow). (D) Foxp3-negative T lymphocytes in the PTC (arrow).

Figure 5. Immunostaining for Foxp3 (DAB stain × 1000). (A) Foxp3-positive controls. (B) Foxp3-negative controls (arrow). (C) Foxp3-negative T lymphocytes in the glomerulus (arrow). (D) Foxp3-negative T lymphocytes in the PTC (arrow).

Table 3. Quantitative analysis of biopsy findings for the diffuse C4d and focal C4d groups.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.